Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes

Overview of attention for article published in Diabetes, Obesity & Metabolism, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 7 X users
peer_reviews: 1 peer review site

guideline: 1 clinical guideline source

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 32,095 followers.

RT @RodolfoJGalindo: Humble and honored by #topdownloadedarticle at Diab, Obesity, and Metabolism https://t.co/BVmIvnbrH4 #Degludec use…

Humble and honored by #topdownloadedarticle at Diab, Obesity, and Metabolism https://t.co/BVmIvnbrH4 #Degludec use in hospitalized patients https://t.co/m157eTuqd1

RT @RodolfoJGalindo: Advancing the field of ultra-long acting insulin: why would you not use Degludec (vs. Glargine U100) in hospitalized p…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.